Filter News
Area of Research
- (-) Neutron Science (11)
- Biology and Environment (24)
- Clean Energy (23)
- Computational Biology (1)
- Computational Engineering (1)
- Computer Science (4)
- Fusion and Fission (2)
- Isotopes (1)
- Materials (7)
- Materials for Computing (4)
- National Security (17)
- Nuclear Science and Technology (1)
- Sensors and Controls (1)
- Supercomputing (35)
News Topics
- (-) Big Data (2)
- (-) Coronavirus (8)
- (-) Security (2)
- 3-D Printing/Advanced Manufacturing (6)
- Advanced Reactors (1)
- Artificial Intelligence (6)
- Bioenergy (6)
- Biology (5)
- Biomedical (11)
- Biotechnology (1)
- Chemical Sciences (2)
- Clean Water (2)
- Climate Change (1)
- Composites (1)
- Computer Science (13)
- Cybersecurity (1)
- Decarbonization (2)
- Energy Storage (6)
- Environment (8)
- Fossil Energy (1)
- Frontier (1)
- Fusion (1)
- High-Performance Computing (2)
- Machine Learning (3)
- Materials (14)
- Materials Science (23)
- Mathematics (1)
- Microscopy (3)
- Nanotechnology (10)
- National Security (2)
- Neutron Science (100)
- Nuclear Energy (3)
- Physics (9)
- Polymers (1)
- Quantum Computing (1)
- Quantum Science (7)
- Space Exploration (3)
- Summit (6)
- Sustainable Energy (2)
- Transportation (5)
Media Contacts
The Department of Energy’s Office of Science has selected three ORNL research teams to receive funding through DOE’s new Biopreparedness Research Virtual Environment initiative.
A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.
More than 50 current employees and recent retirees from ORNL received Department of Energy Secretary’s Honor Awards from Secretary Jennifer Granholm in January as part of project teams spanning the national laboratory system. The annual awards recognized 21 teams and three individuals for service and contributions to DOE’s mission and to the benefit of the nation.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.
To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.
A team of researchers has performed the first room-temperature X-ray measurements on the SARS-CoV-2 main protease — the enzyme that enables the virus to reproduce.
COVID-19 has upended nearly every aspect of our daily lives and forced us all to rethink how we can continue our work in a more physically isolated world.
Research by an international team led by Duke University and the Department of Energy’s Oak Ridge National Laboratory scientists could speed the way to safer rechargeable batteries for consumer electronics such as laptops and cellphones.